title: Amphotericin B: is a lipid-formulation gold standard feasible?
authors.forename: Brad
authors.initials: B
authors.lastname: Spellberg
authors.forename: Mallory D
authors.initials: MD
authors.lastname: Witt
authors.forename: C Keith
authors.initials: CK
authors.lastname: Beck
mesh_terms: D000666:Amphotericin B / Q000737:chemistry / Q000191:economics / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000737:chemistry / Q000191:economics / Q000627:therapeutic use*; D002626:Chemistry, Pharmaceutical; D003362:Cost-Benefit Analysis; D006801:Humans; D008055:Lipids / Q000737:chemistry*; D009181:Mycoses / Q000188:drug therapy*
chemical_list: D000935:Antifungal Agents; D008055:Lipids; D000666:Amphotericin B